Effect of interferon-alpha on interstitial collagenase gene expression in rat liver fibrosis

World Chinese Journal of Digestology

Volumn 9, Issue 1, 2001, Pages 20-23

  Wang, Y ^a   Gao, Y ^a   Yu, J L ^a   Huang, Y Q ^a   Jiang, X Q ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Extracellular matrix; Gene expression; Interferon alpha; Liver cirrhosis; Metalloproteinases; Polymerase chain reaction; Rats

Indexed keywords

ALPHA INTERFERON; CARBON TETRACHLORIDE; COLLAGENASE 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION REGULATION; IMMUNOSTIMULATION; INTERMETHOD COMPARISON; LIVER FIBROSIS; MESSENGER RNA SYNTHESIS; NONHUMAN; QUANTITATIVE ASSAY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0035137020     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Short-and long term effect of interferon therapy of patients with chronic hepatitis C
2. Interferon beta in the treatment of multiple sclerosis: Mechanisms of action
3. Interferon treatment of HCV positive cirrhotic patients
4. Short-and long-term effect of interferon therapy in chronic hepatitis C
5. Effect of interferon in combination with ribavirin on the plus and minus strands of HCV RNA in patients with chronic hepatitis C
6. Comparison of human leukocyte interferon and recombinant interferon alpha-1 in the treatment of chronic hepatitis B
7. Inhibition of combined IFN and chemotherapeutic drugs on gastric cancer cells
8. Therapeutic effect of medicinal herbs and western drugs on hepatitis B virus
9. Effects of long-term administration of interferon α in two models of liver fibrosis in rats
10. 2b
11. Interferon inhibits lipocyte activation and extracellular matrix mRNA expression during experimental liver injury: Implication of hepatic fibrosis
12. Interferon decreases hepatic stellate cell acticvation and extracellular matrix deposition in rat liver fibrosis
13. Changes in serum fibrogensis markers during IFN therapy for chronic hepatitis type C
14. Interferon alpha 2b therapy reduces liver fibrosis in chornic non-A, non-B, hepatitis
15. Modulation of collagen synthesis and degradation by retinoids and cytolines in 3T3 L1 preadippcytes
16. Mechanisms of hepatic fibrosis
17. Fibrosis and altered matrix degration
18. Matrix metalloproteinases and their inhibitors expression in rat liver fibrosis
19. Interstitial collagenase expression in the process of rat experimental liver fibrosis
20. Gelatinase A proenzyme expression in the process of experimental liver fibrosis
21. Differential expression of matrix metalloproteinase-1 and -2 genes in normal and fibrotic human liver
22. Altered balance between matrix metalloproteinases and their inhibitor in experimental biliary fibrosis
23. Collagenase in experimental carbon tetrachloride cirrhosis of the liver
24. Quantitative analysis of MDRI (multidrug resistance)gene expression in human tumors by polymerase chain reaction
25. The pathogenesis of liver fibrosis
26. Mechanism and serum diagnosis of liver fibrosis
27. Current situation in studies of gene therapy for liver cirrhosis and liver fibrosis
28. Diagnosis and treatment of liver fibrosis
29. Fat-storing cells and liver fibrosis
30. Pathogenesis of liver fibrosis
31. 1 and α in chronic liver disease. Effects of IFN-α therapy
32. Interferon γ reverses the stimulation of collagen but not fibronectin gene expression by transforming growth factor-beta in normal human fibroblasts